Key facts
- This page summarizes Ian Michael Estepan's Form 4 filing for Sarepta Therapeutics, Inc. (SRPT).
- 4 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2026, 08:00.
Ian Michael Estepan - 26 Feb 2026 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- SRPT
- Reported as of
- 26 Feb 2026
- Net transaction value
- +$102,140
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2026, 08:00:04 UTC
- Prior SEC filing
- 27 Feb 2026
- Next SEC filing
- 03 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ian Michael Estepan filed Form 4 for Sarepta Therapeutics, Inc. (SRPT) on 02 Mar 2026.
Change
- Previous filing in this sequence was filed on 27 Feb 2026.
- Current net transaction value: +$102,140.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001836254
Primary reporting owner
Estepan Ian Michael
- Relationship
- Chief Operating Officer
- Address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE
- Signature
- /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ian Michael Estepan
- Signature date
- 02 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRPT
transaction
Common Stock
Options Exercise
- Transaction value
- $28,366
- Shares
- +2,069
- Change %
- +1.1%
- Price
- $13.71
- Shares after
- 195,369
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
SRPT
transaction
Common Stock
Options Exercise
- Transaction value
- $73,774
- Shares
- +5,381
- Change %
- +2.8%
- Price
- $13.71
- Shares after
- 200,750
- Date
- 26 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SRPT
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -2,069
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,069
- Exercise price
- $13.71
SRPT
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -5,381
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 26 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,381
- Exercise price
- $13.71
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares held by the Reporting Person after the exercise of a stock option.